Since becoming Apricus Biosciences Inc.'s general counsel in January 2011, Randy J. Berholtz has helped lead the company through several shifts in corporate strategy and built an in-house legal team, all while helping guide several key products to market.
The San Diego-based company develops a biotechnology called NexACT that enables drugs to rapidly penetrate the skin and other biological membranes. Its two main products, erectile dysfunction drug Vitaros and Fempr... (continued)
May 5, 2013
Randy J. Berholtz
Executive Vice President, General Counsel and Secretary for Apricus Biosciences Inc. San Diego
Read more about Randy J. Berholtz...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In